Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
53,311,882
-
Total 13F shares
-
1,389,172
-
Share change
-
+630,489
-
Total reported value
-
$12,132,953
-
Price per share
-
$8.74
-
Number of holders
-
28
-
Value change
-
+$3,180,324
-
Number of buys
-
25
-
Number of sells
-
6
Institutional Holders of Aktis Oncology, Inc. - Common Stock, $0.0001 par value per share (AKTSQ) as of Q2 2017
As of 30 Jun 2017,
Aktis Oncology, Inc. - Common Stock, $0.0001 par value per share (AKTSQ) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,389,172 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, NORTHERN TRUST CORP, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, PRECEPT MANAGEMENT LLC, EAM Investors, LLC, D.A. DAVIDSON & CO., and Bank of New York Mellon Corp.
This page lists
28
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.